Thrive Track for Young Adults With Thyroid, Melanoma, and Testicular Cancer

This trial tests a new tool called Thrive Track to determine if it improves the emotional well-being of young adults who have survived thyroid, melanoma, or testicular cancer. The goal is to assess whether adding Personalized Cancer Support to standard cancer information reduces worry and enhances quality of life. Participants will receive either the cancer information alone or the information plus emotional support content to compare effects. Suitable candidates have lived with thyroid, melanoma, or testicular cancer for 2-10 years and frequently worry about their cancer. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance emotional support for cancer survivors.

The trial information does not specify whether you need to stop taking your current medications. Since the study involves surveys and an informational website, it's unlikely that you will need to change your medication routine.

Research has shown that Thrive Track, a personalized tool, helps young adult cancer survivors manage worry and stress. These feelings are common and can affect daily life. Thrive Track, a digital tool, does not require medication or physical treatments, reducing the likelihood of physical side effects.

Researchers are excited about the Thrive Track because it offers a personalized cancer support experience for young adults with thyroid, melanoma, and testicular cancer. Unlike standard treatments that focus primarily on medical interventions like surgery, chemotherapy, or radiation, Thrive Track provides valuable survivorship care information tailored to each individual's cancer journey. Additionally, one arm of the trial includes emotional support content, which aims to address the psychological and emotional challenges often overlooked in traditional care. This holistic approach could enhance overall well-being and quality of life for young cancer survivors, making it a promising complement to existing treatment options.

Research has shown that young adults who survive cancers such as thyroid, melanoma, and testicular cancer often face significant emotional challenges. Studies have found that psychosocial support can reduce worry and distress, improving quality of life. In this trial, participants in Arm I will access the Thrive Track website, which provides general cancer-specific survivorship care information. Participants in Arm II will receive the same information, plus additional emotional support content. Early results suggest that tools like Thrive Track, which combine cancer-specific information with personalized emotional support, may be more effective than information alone. This support is vital for managing emotional well-being, crucial for young adults dealing with cancer. The evidence-based strategies in Thrive Track aim to help survivors better cope with emotional stress.¹²³⁶⁷